Partnership Wealth Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-78,136
Closed -$1.59M 194
2024
Q2
$1.59M Sell
78,136
-47,614
-38% -$843K 1.17% 18
2024
Q1
$2.15M Buy
125,750
+1,371
+1% +$21.6K 1.51% 17
2023
Q4
$1.96M Buy
+124,379
New +$2.51M 1.48% 21

Other funds holding CLB

Partnership Wealth Management's CLB Position: Q3 2024 in Review

Partnership Wealth Management sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 78,136 shares — an estimated $1.59M sold.

Partnership Wealth Management first reported a position in CLB in Q4 2023 and held it in 3 quarters. The position peaked at $2.15M in Q1 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Partnership Wealth Management reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Partnership Wealth Management sold 78,136 Core Laboratories shares in Q3 2024, an estimated $1.59M.
  • Partnership Wealth Management first reported a position in Core Laboratories in Q4 2023 and held it in 3 quarters.
  • Partnership Wealth Management's Core Laboratories position peaked at $2.15M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Partnership Wealth Management's 13F filing for Q3 2024, filed 8 Oct 2024.